RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @OmegaDiagnostic: As time goes on, we are learning more about how this virus behaves, how our bodies fight the infection and the role th…
RT @ellerby_dave: #ODX Partner @Abingdon_Health provide news again Can you @OmegaDiagnostic @WalbrookPR support that with a tweet? https:/…
RT @allbouncesurrey: #ODX..👀👀👀😷📈 https://t.co/S2wWBlFB8T
#ODX..👀👀👀😷📈
#ODX Partner @Abingdon_Health provide news again Can you @OmegaDiagnostic @WalbrookPR support that with a tweet?
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral #antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis.' 👉https://t.co/CCZ574GCUS #UKRTC #sarscov2 #covid19 h
@Drmartyufml Et si on parlait IMMUNITE au lieu de jouer sur le vocable de la peur? Comment se fait-ce que ds cette étude 91% des rétablis du Covid ai encore des ANTICORPS et ceci jusqu'à 4 mois après le diagnostic, sans qu'ils ne déclinent! # Système immun
@frankarmstrong2 As it happens Iceland gives us a solid bit of research on the question of anti body durability because after a similar time period ( 4 months ) they follow up tested PCR positive cases for antibodies. 91% were seropositive https://t.co/U
@frankarmstrong2 Thread on Iceland here for you
@Choupi_Ko @vincentglad @Cest__Carre Etrange qu'on retrouve dans cette étude des anticorps chez 91% des personnes qui ont développé le covid, jusqu'à 4 mois après le diagnostic et sans que ceux-ci déclinent ...https://t.co/7LORKZ1F1S
RT @AscotBlack: (1) THREAD Hallo @hendrikstreeck, Sie schrieben uns gestern, dass es 2 weitere Studien gebe, die eine ähnl. Sterblichkeit…
RT @hendrikstreeck: Two recent publications show a similar Infection fatality rate as we found in Heinsberg: Heinsberg:0.36 (95% CI,0.29 to…
Und noch mal hoch damit!!! @hendrikstreeck
@GilbertDeray Plus de 91% à 4 mois en Islande. (https://t.co/CqniLZOza1)
@gummibear737 Seroprevalence isn't that misleading. Studies find that 58-91.1% of infected persons do develop detectable antibodies: https://t.co/KdtN0OzetN
@marcus_gerhards @Fonque99 Studien zu IFR: 0,26% - 0,3% https://t.co/sOZTIeArHr und https://t.co/FtYcga0rbY https://t.co/deo2pnikwt
@NomeNominandum @Matinazwazajeta @Mateusz86344252 @Ryszard39144183 @GrzegorzBraun_ @KancelariaSejmu @pisorgpl @KONFEDERACJA_ @RyszardTerlecki https://t.co/V3BU7NataP Skoro nie prof. Rutkowski, to proszę do analizy. Na temat noszenia lub nienoszenia masek
RT @hendrikstreeck: Two recent publications show a similar Infection fatality rate as we found in Heinsberg: Heinsberg:0.36 (95% CI,0.29 to…
@vercheckt @c_drosten 2. Selective Samples: https://t.co/f2i6Cyl7pT 3. Untererfassung bei Seroprävalenzstudien: kommt auf die Methode an: die "einfachen" AK-Studien basierend auf IgG/IgM - auf jeden Fall - https://t.co/xE7nA7XbfU (zwei Pan-Ig-Test am Best
@gummibear737 @AlistairHaimes @deeksj @mgmgomes1 @DrEliDavid @ProfKarolSikora
Humoral Immune Response to SARS-CoV-2 in Iceland. Results: antiviral antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis. risk of death: 0.3% @BallouxFrancois @ClareCraigPath @ProfKarolSikora https://t.co/YBpoazjThc
@bcaramelli Engraçado. Eu tenho navegado na NEJM, por exemplo, que é uma revista de medicina de "impacto" e de mutcha credibilidade. Vejo um monte de referências pré-print. Devo ignorar tudo? https://t.co/Kf0cORqbZr
@WojekJuzek link do publikacji, o której pisałem: https://t.co/7lVhLbSsgL
RT @hendrikstreeck: Two recent publications show a similar Infection fatality rate as we found in Heinsberg: Heinsberg:0.36 (95% CI,0.29 to…
@Stohrm2 @MrP47534295 @faznet Es gibt eine Studie, die von Island beauftragt wurde. Aus der geht es hervor. https://t.co/J65U474ME1
@Michael01130273 @boller60048390 @ronniegrob @M_T_Franz Wenn Sie nach 7 Monaten immer noch nicht Unterschied zwischen CFR und IFR kennen, kann ich Ihnen vermutlich auch nicht mehr helfen. https://t.co/7iXkau182X
Podle těchto čísel by i dost přesně seděla smrtnost 0,3% podle studie z Islandu https://t.co/Bsyn7qkuqj. Do dnešního dne bychom při vynechání posledních 2-3 týdnů, které se ještě neprojevili měli mít 671-972 úmrtí. A aktuálně je 727
@MrsSophieFresco @MartinFrdric7 https://t.co/7LORKZ1F1S Our results indicate that antiviral antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis
@dongdon49026332 @saghult @chrisforsne Yup, IIRC motivating it with not knowing how long antibodies last (and maybe hoping for some kind of innate immunity where you wouldn't develop antibodies after exposure, but can't remember for sure). This makes sero
4/G This includes confirmation by research published after their method. For example: Their Iceland IFR: ~0.4% Ice serology study: 0.3% (CI: 0.2% - 0.6%) https://t.co/bXzVbr26Cz https://t.co/jSiXPTb3cr
@arbiterinator @SallgoodIt @gtconway3d *may* because long term studies simply haven’t been available yet, so that’s all you can definitively conclude. But there are studies that show steady antibody levels through at least 4 months. https://t.co/GffegO6fj
RT @pre176: @PamWhatley2 @marciasmilack @SallgoodIt @gtconway3d Haven’t seen the 39, but I did see the 3rd in the USA a couple days ago and…
@PamWhatley2 @marciasmilack @SallgoodIt @gtconway3d Haven’t seen the 39, but I did see the 3rd in the USA a couple days ago and some other reports from the world. The official guidance is 3 months because long term studies simply aren’t possible yet. But i
@SiobhanGilbert This study with ~1k subjects found antibodies after 4 months without decline: https://t.co/vqQfNerL9R (But I agree there are other results that found a decline)
@OYCar Fair enough but i think the Iceland (https://t.co/6bVoF7pcnC) and Qatar (https://t.co/s5sgYouaYq) study has shown it is possible to achieve 90% lower bounds with the right test. https://t.co/U6Gq3coWAS
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @ellerby_dave: #odx On the move tomorrow https://t.co/ibn4KN0KxJ
RT @ellerby_dave: #odx On the move tomorrow https://t.co/ibn4KN0KxJ
RT @ellerby_dave: #odx On the move tomorrow
RT @Raiders_Revenge: #ODX All falling into place https://t.co/ETp5vs1LbC
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
RT @ellerby_dave: #odx On the move tomorrow
RT @EricTopol: Very good news on durable IgG antibodies to #SARSCoV2 from the Iceland experience Just published @NEJM https://t.co/0sWKSb2…
RT @ellerby_dave: #odx On the move tomorrow https://t.co/ibn4KN0KxJ
RT @ellerby_dave: #odx On the move tomorrow
RT @ellerby_dave: #odx On the move tomorrow
RT @ellerby_dave: #odx On the move tomorrow
#odx On the move tomorrow
RT @Raiders_Revenge: #ODX All falling into place https://t.co/6qaFYiLVhS https://t.co/ETp5vs1LbC
RT @Abingdon_Health: Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral…
#ODX All falling into place https://t.co/ETp5vs1LbC
Interesting article about longevity of SARS-CoV-2 antibody positivity post infection. 'Results indicate that antiviral #antibodies against SARS-CoV-2 did not decline within 4 months after diagnosis.' 👉https://t.co/e4JtpiFgyK #UKRTC #sarscov2 #covid19 h
Sars-CoV-2 https://t.co/eA7lwdTT2F
@lejooon @OscarTengmark Den isländska studien verkar tyda på att nivåerna inte går ner på 4 månader iaf. Lite rörigt. Vore bra om någon försökte modellera den kumulativa summan. https://t.co/gZAnADk4sF
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
@Heimatgalaxie @MisterErrorr @epsilon3141 @markrudolph2701 Und es gibt auch Studien über die Gefärhlichkeit von Sars2Cov. Von den durch den Lockdown zerstörten Leben haben wir auch noch nicht geredet. https://t.co/KdVP1xchIb
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…
Ça n'étonnera personne, mais quand même... Citer un article et conclure L'INVERSE de ce qui est écrit noir sur blanc dans "conclusion", c'est très fort ! (ou pas) Si ça c'est pas de la désinformation https://t.co/pUJFIIbUkq
RT @medicalfollower: 🇮🇸 NEJM- Étude Islandaise sur 30576 patients, les anticorps COVID-19 ont duré au alentour de 4 mois La faible sero-pr…